Benzinga's Top Downgrades

Loading...
Loading...

 

  • Analysts at Wells Fargo downgraded Citigroup Inc C from Outperform to Market Perform. Citigroup shares gained 1.91 percent to $42.08 in pre-market trading.
  • BTIG downgraded T2 Biosystems Inc TTOO from Buy to Sell. The price target for T2 Biosystems has been lowered from $12 to $4. T2 Biosystems shares fell 3.30 percent to close at $7.61 on Thursday.
  • Wells Fargo downgraded Phillips 66 PSX from Outperform to Market Perform. Phillips 66 shares gained 0.04 percent to $74.30 in pre-market trading.
  • Analysts at Bernstein downgraded Advanced Micro Devices, Inc. AMD from Market Perform to Underperform. AMD shares fell 4.38 percent to $4.80 in pre-market trading.
  • UBS downgraded NiSource Inc. NI from Buy to Neutral. The price target for NiSource has been raised from $25 to $27. NiSource shares declined 2.29 percent to close at $26.04 on Thursday.
  • Analysts at Wedbush downgraded WhiteWave Foods Co WWAV from Outperform to Neutral. WhiteWave Foods shares gained 0.04 percent to $56.25 in pre-market trading.
  • Analysts at Citi downgraded AT&T Inc. T from Buy to Neutral. The price target for AT&T has been raised from $42 to $46. AT&T shares slipped 0.28 percent to $42.18 in pre-market trading.
  • Canaccord Genuity downgraded Transocean LTD RIG from Hold to Sell. Transocean shares rose 0.50 percent to $12.02 in pre-market trading.
  • Nomura downgraded AVG Technologies NV AVG from Buy to Neutral. The price target for AVG Technologies has been lowered from $30 to $25. AVG Technologies shares climbed 30.81 percent to close at $24.58 on Thursday.
  • JP Morgan downgraded Juno Therapeutics Inc JUNO from Overweight to Neutral. The price target for Juno Therapeutics has been lowered from $63 to $39. Juno Therapeutics shares dipped 24.69 percent to $30.74 in pre-market trading.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...